
Professor for Infectious Disease with focus on Hepatology, Hannover Medical School, Director of the Centre for Individualised Infection Medicine @Helmholtz_CiiM
Hannover
Joined November 2020
- Tweets69
- Following265
- Followers275
- Likes143
Non-selective beta blockers reduce bystander CD8+ T cell activation in decompensated liver cirrhosis biorxiv.org/content/10.1101/… #biorxiv_immuno
Markus Cornberg retweeted
EASL is deeply saddened to share the news of the passing of Professor Michael P. Manns (1951–2025).
A visionary leader in hepatology, Professor Manns shaped the field through his pioneering research in viral hepatitis, autoimmune liver diseases, transplantation and regenerative medicine. He served as Director of the Department of Gastroenterology, Hepatology and Endocrinology at Hannover Medical School for nearly three decades, and held leading roles in Hep-Net, the German Liver Foundation, UEG, and EASL.
His scientific excellence, dedication and mentorship inspired colleagues around the world. Professor Manns received numerous awards, including the EASL Recognition Award (2007) and the UEG Lifetime Achievement Award (2022).
EASL extends heartfelt condolences to his family, friends and colleagues. His legacy will continue to inspire generations of hepatologists.
Markus Cornberg retweeted
📢 The updated #HBV guidelines were just presented by @CornbergMarkus @ #EASLcongress.
✔️ Focus on shared decision-making
✔️ Simplified treatment algorithm
✔️ Clear answers to key questions:
👉Who to treat?
👉When to start?
👉What are the #HCC risk factors?
👉What if ALT is normal but HBV DNA is high?
@JHepatology @EASLnews
#LiverX
⭐️ New EASL CPGs on the management of hepatitis B virus infection.
👉Read here: authors.elsevier.com/a/1l3v2…
Markus Cornberg retweeted
⭐️ New EASL CPGs on the management of hepatitis B virus infection.
👉Read here: authors.elsevier.com/a/1l3v2…
🆕CPG in press❕
EASL Clinical Practice Guidelines on the management of hepatitis B virus infection
Find it here👉bit.ly/4deZHf1
@EASLnews
@EASLedu
Markus Cornberg retweeted
Honoured to be part of the #EASL #HBV #CPG! 😊😊😊
EASL Clinical Practice Guidelines on the management of hepatitis B virus infection
Free text here: authors.elsevier.com/a/1l3v2…
#EASLCongress
Markus Cornberg retweeted
Check out our preprint here: biorxiv.org/cgi/content/shor…
#HBV #chronicHBV #tcell #immunotherapy #immune-checkpoint-inhibitor #ICI #epigenetics #DNMT #DNMT-inhibitor #Decitabine #DAC
@KraftAnke @CornbergMarkus
Markus Cornberg retweeted
Das @Helmholtz_CiiM, eine gemeinsame Initiative des HZI & @MHH_life, widmet sich der individuellen Diagnostik und Therapie von #Infektionskrankheiten. Heute konnte beim Bau für das CiiM-Gebäude Richtfest gefeiert werden!
helmholtz-hzi.de/media-cente…
Markus Cornberg retweeted
Today it was time for the last nails during the topping-out ceremony of CiiM, a joint initiative of @helmholtz_hzi and @MHH_life, realized with funds from @BMBF_Bund, Lower Saxony's Minister for Science and Culture (MWK) and @helmholtz_de.
Markus Cornberg retweeted
🆕High Prevalence & Clinical Relevance of Intrapulmonary Vascular Dilatations in Patients Undergoing TIPS Implantation
📈risk of cardiac & hepatic decompensation
💡patient selection & individualized post-TIPS care!
Mauz et al in CGH:
🔓 bit.ly/4c7bqua #livertwitter
Markus Cornberg retweeted
#EASLStudio: why a functional HBV cure is needed?
1. NUCs cannot neutralise cccDNA
2. A cure can improve endpoints
3. Decrease long term monitoring ➡️ reduce costs
4. DNA testing not easy to get, but HBsAg easy to check
5. Reduce stigma
@EASLnews #livertwitter
Markus Cornberg retweeted
Replying to @YangLi_Lab
@YangLi_Lab opened the annual @DZIF_ Meeting in #Hannover. 2 days of exciting translation research on #infection at the beautiful venue in Herrenhausen
Markus Cornberg retweeted
Why you should be careful when picking mushrooms explains @CornbergMarkus
Immer mehr Patienten, schon ein Toter: MHH schlägt Giftpilz-Alarm m.bild.de/regional/hannover/…
Markus Cornberg retweeted
We are looking forward to the new @Helmholtz_CiiM building. Construction progress is already clearly visible #ConstructionCiiM. – at Hanover, Germany
Markus Cornberg retweeted
🚨EASL Highlights webinar
🕔 4th of July, 5pm-7pm (CET)
Tune in tomorrow for a summary of the most important topics from #EASLCongress, presented by the Hannover Liver team @HeinerWedemeyer @CornbergMarkus @b_maasoumy!
➡️ register at livercongressnews.com/easl-h…
#livertwitter
Markus Cornberg retweeted
Wrap-up #HepNetSymposium:
💡Great talks on all types of liver-related diseases
👥 Discussions with leading experts in the field
😊 Happy to be part of #livertwitter and be able to attend this event from #leberstiftung @MHH_life (jm)
Markus Cornberg retweeted
Greetings from #EASLCongress in Vienna from one part of our @LabCornbergKraf 👋🏻
#livertwitter
(ks, muq & mw)
Markus Cornberg retweeted
❓Non-selective beta-blockers #nsbb after TIPS-insertion?
Anja Tiede presents her findings on the impact of NSBB on hepatic decompensation and survival after portal pressure reduction via TIPS today at #EASLCongress 📍SAT-551 @tiede_anja #livertwitter
Markus Cornberg retweeted
A well-taken Poster presentation by @MoanaWitte on inflammatory mediators after HCV cure, the chance to connect with many friends and colleagues from all over the world and on top the chance to enjoy and discover #vienna. Thanks @EASLnews, see you next year at #Milan2024 – at Vienna, Austria
Markus Cornberg retweeted
Listening to our @DSOLVE_EU partner @HeinerWedemeyer presenting newest data on bulevirtide, published yesterday in @NEJM. Great work with Soo Aleman, Pietro Lampertico @CornbergMarkus.
#LiverTwitter, #EASLCongress, #MHH_life, #hepatitisd, #hdv, #hepatitis, #NEJM, #landmarkpaper






























